Principales conclusions et analyse des parts de marché du montélukast sodique d'ici 2025-2031
Montelukast Sodium Market Report Analysis
Montelukast Sodium Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Merck & Co. Inc.
- Morepen Laboratories
- Teva Pharmaceuticals USA Inc.
- Mylan NV
- Cipla Limited
- Intas Pharmaceuticals Ltd
- SUN PHARMA
- Apotex Inc
- Sanyo Chemical Industries Ltd
Regional Overview

- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation

- montélukast sodique amorphe
- montélukast sodique cristallin

- comprimés
- comprimés à croquer
- solutions orales

- asthme
- rhinite allergique
- urticaire
- autres applications

- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale